ENTERIC COATING, COMPRISING ALGINIC ACID, FOR AN ORAL PREPARATION

Abstract: A composition for formation of an enteric coating on an oral product comprising a liquid mixture of alginic acid particles and a binding agent, and oral preparation having an enteric coating formed on the basis of such a composition.

Description: ENTERICCOATING, COMPRISING ALGINIC ACID, FOR AN ORALPREPARATION The present invention relates to a composition for forming an enteric coating on an oral preparation, such as a preparation in the form of tablets, capsules or pellets. Enteric coatings are taken to mean coatings which i.a. serve to prevent an undesired influence upon the active substance contained in the oral preparation in the stomach. Enteric coatings are for example used for (1) preventing the gastric juice from reacting with or destroying the active substance, (2) preventing dilution of the active substance before it reaches the intestine, (3) ensuring that the active substance is not released until after the preparation has passed the stomach, and (4) preventing that live bacteria contained in the preparation are killed because of the low pH-value in the stomach. Enteric coatings can also be used for avoiding irritation of or damage to the mucous membrane of the stomach caused by substances contained in the oral preparation, and for counteracting or preventing formation or release of substances having an unpleasant odour or taste in the stomach. Finally, such coatings can be used for prevent¬ ing nausea or vomiting on intake of oral preparations. It is known to prepare enteric coatings from one or more layers of fatty acids, such as stearic acid and palmitic acid, wax, shellac and/or cellulose acetate phthalate. It is an essential disadvantage of the known enteric coating compositons that use of organac solvents in the form of acetone or chlorine containing compounds is required for their formation. As regards cellulose acetate phthalates it further applies that they must not be used for coating foodstuffs and food supplements, as they are not approved for use m foodstuffs m the EU, cf. "Fortegnelse over tilsaetnings- stoffer til levnedsmidler", Positivlisten, Lev edsmiddel- styrelsen, December 1995, Publ. No. 231, ISSN 0903-9783, ISSN 0108-1667. Another known coating composition is acrylic resin which is available in commerce under the trade mark Eudragit®, but this coating composition also is not generally approved for formation of coatings on foodstuffs. It has now surprisingly been found that a known substance, which has been approved for use as additive for foodstuffs, is useful for forming effective enteric coatings on oral preparations when it is combined with a binding agent. Thus, it has turned out that by forming a layer of a liquid mixture of alginic "id particles and binding agent on a preparation in e form of tablets, capsules, pellets and the like, a coating is obtained which is resistant to influence of gastric juice, and which dis¬ solves under neutral or basic conditions. This is due to the fact that alginic acid is insoluble in acids and soluble in basic or neutral media and hereby in a manner known per se forms alginate. The best protective effect is obtained when the alginic acjd particles in the mixture of alginic acid and binding agent have an average particle size of maximally 2 μm, but depending on the kind of the preparation to be provided with an enteric coating, larger and smaller particles can be used. A particularly good protective effect is obtained by using a mixture of alginic acid particles with varying particle sizes. As binding agent for the alginic acid particles, a wide variety of therapeutic and/or nutritionally acceptable binding agents can be employed. The binding agent is preferably dissolved in the liquid medium, and examples of binding agents useful in connection with drugs as well as foodstuffs and food supplements, include locust bean gum, gelatine, vegetable hydrocolloids and animal proteins . The liquid mixture of alginic acid particles and binding agent is preferably aqueous, and the water preferably makes up more than 95 % of the weight of the mixture. The ratio of alginic acid to binding agent may vary within wide limits depending on the binding agent, the particle size of the alginic acid, and the field of application of the coating composition. Typically, alginic acid and binding agent are used in a weight ratio from 4:1 to 0.5:1. When using an aqueous mixture of alginic agent and bind¬ ing agent, such as locust bean gum, the latter is prefer¬ ably dissolved in a portion of the water, and the alginic acid is slurried in the remaining portion of the water, whereafter the slurry is optionally subjected to a treat¬ ment, e.g. in a homogenizer, in order to obtain the desired particle size. Finally, the two fractions are mixed, and optionally a further homogenization is per¬ formed in order to distribute the alginic acid in the firstmentioned fraction. The liquid mixture of alginic acid and binding agent may also contain various additives. For example, softening agent in the form of an oil, such as olive oil, and detackiflers, such as magnesium stearate, and fats may be used. The formation of an enteric coating on an oral prepara¬ tion using the coating composition according to the invention can take place m a manner known per se, e.g. by direct spraying of the liquid mixture of alginic acid and binding agent on the preparation in a fluid bed or a coating pan. The invention also concerns a preparation provided with an enteric coating prepared by using the coating composition according to the invention. Oral preparations which are coated with enteric coating according to the present invention are particularly suitable for containing live organisms, such as freeze- dried bacteria. Further, the invention relates to a process for the preparation of an enteric coating on an oral preparation containing live organisms, which process does not employ toxic organic solvents, and m which the temperature does not exceed about 30 °C. When coating an oral preparation containing live organisms, e.g. freeze-dried bacteria, it is important that the bacteria are not exposed to extraneous influences which may entail that the bacteria are damaged or at worst die. Use of toxic organic solvents and high temperatures in the preparation of enteric coatings on the oral prepara- tion should consequently be avoided. In the present invention for the preparation of enteric coatings on the oral preparation, the temperature preferably does not exceed about 30 °C. Further, no toxic organic solvents are used. In a further embodiment of the process according to the present invention, the oral preparation which is coated with the enteric coating is constituted by capsules, preferably gelatine capsules. If a preparation in the form of capsules is used, also a gentle preparation of the active substance is obtained prior to it being coated with the enteric coating, as the physical conditions during the preparation of the capsules do not influence the active substance. The active substance, e.g. in the form of freeze-dried bacteria, is filled into empty capsules, as opposed to tablets and pellets where the active substance participates in the preparation of the tablet or pellet. The enteric coating has turned out to be particularly effective for capsules of gelatine. Depending on the kind of the preparation, it may be desirable to build the enteric coating from several layers, one of which is constituted by fine grained alginic acid particles bonded by a binding agent. For example, it may be desirable to prepare a coating consisting of four layers, where one of the centre layers is prepared from the coating composition according to the invention. It may also be desirable to provide an inner layer consisting of several sub-layers. Similarly, the outer layer may be built from several layers. In the following the invention is described in more detail, reference being made to the following example. EXAMPLE For use in the preparation of an enteric coating on gelatine capsules containing freeze-dried lactic acid bacteria, the following three coating compositions are employed: Coating composition 1 Zein F-4000 10 % Ethyl alcohol 96 % 79 % Purified water 9 % Magnesium stearate 2 % Coating composition 1 was prepared by slurrying Zein F- 4000 in ethyl alcohol, whereafter the magnesium stearate was admixed. Finally, the water was admixed with stirring. Coating composition 2 Sodium alginate 2.7 % Purified water 97 % Olive oil 0.15 % Magnesium stearate 0.15 % Coating composition 2 was prepared by dissolving sodium alginate in the water, whereafter the olive oil and the magnesium stearate were added and homogenized by means o: a homogenizer. Coating composition 3 Alginic acid 1.5 % Locust bean gum 0.8 % Olive oil 0.8 % Purified water 96.9 % Coating composition 3 was prepared by dissolving 0.8 parts of locust bean gum in 38.4 parts of water, whereafter 0.8 parts of olive oil were added, and the mixture was emulsified with a homogenizer. 1.5 parts of alginic acid were slurried in 58 parts of water and homogenized with a homogenizer, whereafter the above olive oil emulsion was added, and the mixture was homogenized with a homogenizer. The coating compositions used were applied onto the gelatine capsules in the order and under the conditions stated in the table below. As appears from the table above, the water activity m the capsules (measured by means of a "Novasιna"-moιsture meter) does not increase significantly m spite of aqueous coating compositions having been used. This is very important for the stability of many substances and for the survival of freeze-dried bacteria. The finished capsules were tested m accordance witn Ph. Eur. : 6 capsules are exposed to the influence of 0.1N hydrochloric acid at 37 °C for 2 hours in Ph. Eur.'s decay apparatus and must show no signs of dissolution or disruption which allows the content to escape. There¬ after, the acid is replaced by a phosphate buffer solution with pH 6.8. After 60 mm, the capsules must have dissolved. The film coated capsules stood up to this test and had all dissolved after 18 mm in the phosphate buffer. For the purpose of clarifying the stability of lactic acid bacteria containing preparations provided with an enteric coating according to the invention, decay experi- ments were performed in which the number of micro¬ organisms contained in enterically coated capsules were counted, before and after treatment with 0. IN HCI for 2 hours, and at 36-38 °C in accordance with Ph. Eur. 2nd Ed., 478, 1990. The results of these decay experiments appear from the table below. Before treatment Sample No. Number of live lactobacillus pr. gram of MRS agar 37 °C - 3 days, CO^-atmosphere 1 a 7.0 x 10 7 1 b 5.8 x 10' Mean value: 6.8 x 10 7 2 a 7.3 x 10' 2 b 6.9 x 10 7 Sample No. Number of live bifidobacteria pr. gram of RCM agar 37 °C - 5 days, anaerobic 1 a 4.0 x 10 ϋ 1 b 3.9 x 10 8 Mean value: 4.0 x 10 8 2 a 3.8 x 10 a 2 b 4.4 x 10 fl After treatment Sample No. Number of live lactobacillus pr. gram of MRS agar 37 °C - 3 days, C0 2 -atmosphere 1 a 2.0 x 10 7 1 b 1.4 x 10 7 Mean value: 2.7 x 10 7 2 a 3.0 x 10 7 2 b 4.5 x 10 7 Sample No. Number of Jive bifidobacteria pr. gram of RCM agar 37 °C - 5 days, anaerobic 1 a 1.7 x 10' 1 b 1.5 x 10 7 Mean value: 2.0 x lθ' 2 a 2.2 x 10 7 2 b 2.5 x 10 7 s appears from the above results, the acid treatment only results a negligent drop m live micro-organisms

Claims: C 1 a l m 1. A composition for formation of an enteric coating on an oral preparation, c h a r a c t e r i z e d in that it comprises a liquid mixture of alginic acid particles and a binding agent which is approved for use for coating foodstuffs and/or food supplements. 2. A composition according to claim 1, c h a r a c ¬ t e r i z e d in that the alginic acid particles have an average particle size of maximally 2 μm. 3. A composition according to claim 1 or 2, c h a r a c t e r i z e d in that the alginic acid particles have varying particle sizes. 4. A composition according to claim 1, 2 or 3, c h a r a c t e r i z e d in that the binding agent is dissolved in the liquid medium. 5. A composition according to any of the preceding claims, c h a r a c t e r i z e d in that the binding agent is selected from a group consisting of locust bean gum, gelatine, vegetable hydrocolloids, and animal proteins. 6. A composition according to any of the preceding claims, c h a r a c t e r i z e d in that the liquid medium is aqueous. 7. A composition according to any of the preceding claims, c h a r a c t e r i z e d in that the alginic acid particles and the binding agent are present in a weight ratio from 4:1 to 0.5:1. 8. An oral preparation provided with an enteric coating, c h a r a c t e r i z e d in that the enteric coating is prepared using a composition according to any of the preceding claims. 9. An oral preparation according to claim 8, c h a r ¬ a c t e r i e d in that the preparation ccr.rains live bacteria, preferably freeze-dried bacteria. 10. An oral preparation according to claims S-9, c h a r a c t e r i z e d in that it is in tr.e form of tablets, capsules or pellets, preferably gelatine capsules . 11. A process for the preparation of an enteric coating on an oral preparation containing live bacteria, c h a r a c t e r i z e d in that the enteric coating is prepared without using toxic organic solvents and at temperatures of about 30 °C or less. 12. A process according to claim 11, c h a r a c t e r ¬ i z e d in that the oral preparation is in t e form of capsules, preferably gelatine capsules.

Inventors: BRANDSBORG ERIK, MARCUSSEN JOERN, BRANDSBORG, ERIK, MARCUSSEN, JOERN
Applicants: BIFODAN AS, BRANDSBORG ERIK, MARCUSSEN JOERN, BIFODAN A/S, BRANDSBORG, ERIK, MARCUSSEN, JOERN
Application year: 1997
Main classification: A61K9
IPC codes: A23L1, A61K9, A61K35, A61K47